This study was used for assessing the usefulness of anti-TNF-α (infliximab, adalimumab) in the treatment of depression and psoriasis. However, they were found to be effective in treating depression and associated with chronic inflammatory conditions. This evidence concerns the gene TNF and major depressive disorder.